BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14008906)

  • 1. [On the changes of plasmin activity caused by radiation treatment in cancer patients and effects of antiplasmin (Ipsilon) administration].
    YAMASHITA H; IGARI S; TANAKA T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1961 Sep; 21():646-55. PubMed ID: 14008906
    [No Abstract]   [Full Text] [Related]  

  • 2. On the changes of plasmin activity caused by radiation treatment in cancer patients and effects of antiplasmin (ipsilon) administration.
    YAMASHITA H; IGARI S; TANAKA T
    Keio J Med; 1961 Dec; 10():195-207. PubMed ID: 14008905
    [No Abstract]   [Full Text] [Related]  

  • 3. [On plasmin and antiplasmin titration].
    KOTSCHY M
    Postepy Hig Med Dosw; 1961; 15():607-15. PubMed ID: 14458817
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasmin/alpha2-antiplasmin complexes (PAP) in lung cancer patients: effects of radiotherapy.
    Uszyński M; Ziółkowska E; Zekanowska E; Uszyński W
    Thromb Haemost; 2002 Jul; 88(1):169-70. PubMed ID: 12152666
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme.
    AMBRUS CM; MARKUS G
    Am J Physiol; 1960 Sep; 199():491-4. PubMed ID: 13682944
    [No Abstract]   [Full Text] [Related]  

  • 6. [Alpha 2-plasmin inhibitor-plasmin complex].
    Yoshikawa Y
    Nihon Rinsho; 1999 Sep; 57 Suppl():685-7. PubMed ID: 10543213
    [No Abstract]   [Full Text] [Related]  

  • 7. ENHANCEMENT OF FIBRINOLYSIS AND ANTAGONISM OF ANTIPLASMIN BY REVERSIBLE PLASMIN INHIBITORS.
    MAXWELL RE; LEWANDOWSKI V; NICKEL VS
    Life Sci (1962); 1965 Jan; 4():45-51. PubMed ID: 14257064
    [No Abstract]   [Full Text] [Related]  

  • 8. [alpha 2-Plasmin inhibitor-plasmin complex (PIC)].
    Yoshikawa Y; Sakata Y
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():55-8. PubMed ID: 8753179
    [No Abstract]   [Full Text] [Related]  

  • 9. Carbon monoxide and nitric oxide modulate α₂-antiplasmin and plasmin activity: role of heme.
    Arkebauer MR; Kanaparthy SS; Malayaman SN; Vosseller K; Nielsen VG
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):712-9. PubMed ID: 22024794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An enzyme-linked immunosorbent assay (ELISA) for the measurement of plasmin-alpha 2-antiplasmin complex in human plasma--application to the detection of in vivo activation of the fibrinolytic system.
    Holvoet P; de Boer A; Verstreken M; Collen D
    Thromb Haemost; 1986 Oct; 56(2):124-7. PubMed ID: 2433784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of alpha 2 plasmin inhibitor and alpha 2 plasmin inhibitor-plasmin complex by enzyme immunoassay method--with special reference to accident surgery].
    Fukuda C; Iijima K; Inoue N; Takashima Y; Urabe C; Nakamura K
    Rinsho Byori; 1988 Mar; 36(3):346-50. PubMed ID: 2969986
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of plasmin and its complexes with alpha 2-antiplasmin and alpha 2-macroglobulin on secretion of proteinase and plasminogen inhibitors from peripheral mononuclear cells].
    Zhabin SG; Zorin NA; Musatov MI
    Vopr Med Khim; 1995; 41(3):34-7. PubMed ID: 8585176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; alpha 2 plasmin inhibitor plasmin complex].
    Itoh N
    Rinsho Byori; 1989 Apr; Spec No 81():202-7. PubMed ID: 2526884
    [No Abstract]   [Full Text] [Related]  

  • 14. [Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex].
    Kawai Y; Watanabe K
    Rinsho Byori; 1989 Mar; 37(3):248-55. PubMed ID: 2526263
    [No Abstract]   [Full Text] [Related]  

  • 15. [STUDIES ON TRYPSIN INHIBITOR AND ANTIPLASMIN IN HUMAN SERUM. I. ON NORMAL AND ARTERIOSCLEROTIC CASES].
    MATSUDA T
    Nihon Ketsueki Gakkai Zasshi; 1963 Oct; 26():581-9. PubMed ID: 14095688
    [No Abstract]   [Full Text] [Related]  

  • 16. [The significance of measurement of alpha 2PI-plasmin complex in acute promyelocytic leukemia].
    Asakura H; Itoh K; Johkaji Y; Saito M; Uotani C; Kumabashiri I; Matsuda T
    Rinsho Ketsueki; 1988 Apr; 29(4):534-8. PubMed ID: 2969985
    [No Abstract]   [Full Text] [Related]  

  • 17. Alpha-2 plasmin inhibitor-plasmin complex and postoperative blood loss: double-blind study with aprotinin in reoperation for myocardial revascularization.
    Minami K; Notohamiprodjo G; Buschler H; Prohaska W; Reichelt W; Körfer R
    J Thorac Cardiovasc Surg; 1993 Nov; 106(5):934-6. PubMed ID: 7694000
    [No Abstract]   [Full Text] [Related]  

  • 18. Partial purification of bovine antiplasmin (antifibrinolysin).
    COLE ER; DALBY A; MERTZ ET
    Can J Biochem Physiol; 1960 Sep; 38():1021-7. PubMed ID: 13811110
    [No Abstract]   [Full Text] [Related]  

  • 19. Alpha 2-plasmin inhibitor-plasmin complexes in synovial fluid.
    Inman RD; Harpel PC
    J Rheumatol; 1986 Jun; 13(3):535-7. PubMed ID: 2942685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ON THE BEHAVIOR OF PLATELET ANTIPLASMIN IN CONSTITUTIONAL THROMBOPATHY (VON WILLEBRAND-JUERGENS SYNDROME)].
    JUERGENS J
    Verh Dtsch Ges Inn Med; 1964; 70():630-2. PubMed ID: 14294285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.